Genetically Encoded Cholesterol-Modified Polypeptides.

Area of Science:

• Biomaterials Science
• Protein Engineering
• Nanotechnology

Background:

• Post-translational modifications (PTMs) regulate protein function but are underutilized in biomaterial design.
• Lipidation, a natural PTM, offers potential for creating novel biomaterials.
• Genetically encoded recombinant biomaterials are limited.

Purpose of the Study:

• To develop a new class of self-assembling biomaterials using a natural lipidation PTM.
• To demonstrate the biomedical potential of these cholesterol-modified polypeptides (CHaMPs).
• To create a cholesterol-conjugated exendin-4 for type II diabetes treatment.

Main Methods:

• Utilized hedgehog-mediated cholesterol modification of proteins.
• Engineered cholesterol-modified polypeptides (CHaMPs) with programmable self-assembly.
• Conjugated cholesterol to the peptide exendin-4.

Main Results:

• CHaMPs exhibited programmable self-assembly at the nanoscale.
• The exendin-4-cholesterol conjugate self-assembled into micelles.
• These micelles activated the glucagon-like peptide-1 receptor with high potency.

Conclusions:

• Cholesterol modification of proteins is a viable strategy for creating self-assembling biomaterials.
• CHaMPs offer a promising platform for developing advanced drug delivery systems.
• The exendin-4-cholesterol conjugate demonstrates potential as an effective therapeutic for type II diabetes.